Shenzhen Majory Biotechnology Co., Ltd.
2 clinical trials · Sponsor
◉ Watch Shenzhen Majory Biotechnology Co., Ltd.
| Record | Firm | Date |
|---|---|---|
| A Study of MR001 in Patients With Locally Recurrent or Metastatic Advanced Triple-Negative Breast Cancer (TNBC) (NCT07208149) | Shenzhen Majory Biotechnology Co., Ltd. | 2026-01-29 |
| A Study of MR001 Combined With Chemotherapy in Patients With Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma (PDAC) After First-line Therapy (NCT07235202) | Shenzhen Majory Biotechnology Co., Ltd. | 2025-12-24 |
Track Shenzhen Majory Biotechnology Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.